Loading clinical trials...
Loading clinical trials...
Clinical Outcomes of Low Dose Pharmacokinetic-guided Extended Half-life FVIII Concentrates Versus Low Dose Standard Prophylaxis in Thai Severe Haemophilia A Patients
Conditions
Interventions
Extended half-life FVIII concentrates with PK-guided dosing
standard half-life FVIII concentrates with weight-based dosing
Locations
1
Thailand
Pediatric department, Faculty of medicine, Chulalongkorn University
Pathum Wan, Bangkok, Thailand
Start Date
July 1, 2021
Primary Completion Date
March 31, 2022
Completion Date
April 30, 2022
Last Updated
July 20, 2022
Lead Sponsor
Chulalongkorn University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions